Cargando…
Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412365/ https://www.ncbi.nlm.nih.gov/pubmed/37565167 http://dx.doi.org/10.1155/2023/9828565 |
_version_ | 1785086887146291200 |
---|---|
author | Longevity, Oxidative Medicine and Cellular |
author_facet | Longevity, Oxidative Medicine and Cellular |
author_sort | Longevity, Oxidative Medicine and Cellular |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10412365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-104123652023-08-10 Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study Longevity, Oxidative Medicine and Cellular Oxid Med Cell Longev Retraction Hindawi 2023-08-02 /pmc/articles/PMC10412365/ /pubmed/37565167 http://dx.doi.org/10.1155/2023/9828565 Text en Copyright © 2023 Oxidative Medicine and Cellular Longevity. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Retraction Longevity, Oxidative Medicine and Cellular Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study |
title | Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study |
title_full | Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study |
title_fullStr | Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study |
title_full_unstemmed | Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study |
title_short | Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study |
title_sort | retracted: clinical efficacy of peg-ifnα-2a and peg-ifnα-2b in the treatment of hepatitis b e antigen-positive hepatitis b and their value in improving inflammatory factors and hemodynamics in patients: a comparative study |
topic | Retraction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412365/ https://www.ncbi.nlm.nih.gov/pubmed/37565167 http://dx.doi.org/10.1155/2023/9828565 |
work_keys_str_mv | AT longevityoxidativemedicineandcellular retractedclinicalefficacyofpegifna2aandpegifna2binthetreatmentofhepatitisbeantigenpositivehepatitisbandtheirvalueinimprovinginflammatoryfactorsandhemodynamicsinpatientsacomparativestudy |